Congenica

Congenica

Biotechnology Research

Cambridge, Cambridgeshire 11,508 followers

Driving Precision Medicine

About us

Congenica is a digital health company providing software and solutions for the analysis and interpretation of genomic data at scale. We drive Precision Medicine and help reduce the burden on healthcare systems by delivering automated analysis, diagnosis and treatment solutions to healthcare providers and patients worldwide. Congenica’s Platform is the only product of its kind that has received the CE Mark under the In Vitro Diagnostics Directive for both rare diseases and somatic and inherited cancer, and is uniquely placed to drive ubiquitous use of complex data in routine clinical care. Our products and services are consolidated on one single scalable, automated analysis and diagnostic platform that encompasses inherited disease, somatic cancer, pharma insights and pathogen surveillance. Congenica was founded based on pioneering work at the Wellcome Trust Sanger Institute and the UK NHS. We are the exclusive clinical decision support partner for the NHS Genomic Medicine Service and have a global footprint supporting leading international laboratories, academic medical centres, hospitals and biopharmaceutical companies.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Cambridge, Cambridgeshire
Type
Privately Held
Founded
2014
Specialties
Clinical genetics, Whole Genome Sequencing, Next Generation Sequencing, Genetic Variation Analysis, Rare diseases, Genomics, Digital Health, and Empowering Healthcare

Locations

  • Primary

    Biodata Innovation Centre

    Wellcome Genome Campus

    Cambridge, Cambridgeshire CB10 1SA, GB

    Get directions

Employees at Congenica

Updates

Similar pages

Funding

Congenica 7 total rounds

Last Round

Series C

Investors

QVentures
See more info on crunchbase